BDH Industries Ltd (BDH) is currently trading at 371.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

BDH Industries (BDHIL) manufactures a wide range of drug formulations, focusing on antibiotics, anti-inflammatory, and anti-microbial segments. It offers robust Oral Solid Dosages (OSD) technologies. The company boasts a well-equipped R&D center in Mumbai, dedicated to developing novel drug delivery systems, signaling a commitment to innovation. BDHIL has entered into a MoU with Nepal's Nepothene Group to assist in setting up a pharmaceutical company, indicating international strategic collaboration. They expanded into the agro products business as of 2021-22, diversifying their business portfolio. BDHIL invested in renewable energy by commissioning two wind turbine units, highlighting their drive towards sustainability.

Over the past 52 weeks, BDH Industries Ltd has traded between a low of ₹241.00 and a high of ₹523.75. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

BDH Industries Ltd has a market capitalization of approximately 224.24. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

BDH Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.49 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 224.24 Cr, BDH Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

BDH Industries Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of BDH Industries Ltd is 20.49. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.